Announcement PDF Market Announcement 8 July 2020 Recce Pharmaceuticals Ltd (ASX: RCE) – Suspension from Official Quotation Description The securities of Recce Pharmaceuticals Ltd (‘RCE’) will be suspended from quotation immediately under Listing Rule 17.2, at the request of RCE, pending the release of an announcement regarding a material research agreement. Issued by Vanessa Nevjestic Adviser, Listings Compliance (Perth) 8 July 2020 ASX Limited Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au 8 July 2020 Sean Maloney Adviser, Listings Compliance (Perth) Level 40 Central Park 152 - 158 St George’s Terrace PERTH WA 6000 By email: tradinghaltsperth@asx.com.au Dear Sean Recce Pharmaceuticals Ltd (ASX:RCE) – Voluntary Suspension request Pursuant to ASX Listing Rule 17.2, Recce Pharmaceuticals Ltd ACN 124 849 065 (Company) requests for its securities to be voluntarily suspended pending the release of an announcement relating to a Material Research Agreement. The Company requests that the voluntary suspension be effective immediately and remain in place until the earlier of the commencement of normal trading on Thursday, 9 July 2020 or the release of an announcement by the Company in relation to a Material Research Agreement. The Company is not aware of any reason why the voluntary suspension should not be granted. For any questions, please contact the undersigned on +61 2 8072 1400. Yours faithfully Alistair McKeough Company Secretary